DEXCOM INC. DL-,001/ US2521311074 /
| 2025-03-17 7:32:26 AM | Chg. +0.31 | Volume | Bid7:32:26 AM | Ask7:32:26 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 64.71EUR | +0.48% | - Turnover: - |
64.71Bid Size: - | 64.90Ask Size: - | 25.39 bill.EUR | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.46 USD | 4.29% |
| EPS Diluted: | 1.42 USD | 9.23% |
| Revenues per Share: | 10.32 USD | 9.84% |
| Book Value per Share: | 5.38 USD | 0.28% |
| Cash Flow per Share: | 2.53 USD | 30.42% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 4,033.00 USD | 11.34% |
| Net Income: | 576.20 USD | 6.41% |
| Operating Cash Flow: | 989.50 USD | - |
| Cash and Cash Equivalents: | 606.10 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 48.42 | 53.27 |
| P/S Ratio: | 6.85 | 7.54 |
| P/BV ratio: | 13.14 | 14.45 |
| P/CF Ratio: | 27.92 | 30.71 |
| PEG: | 11.30 | 12.43 |
| Earnings Yield: | 2.07% | 1.88% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 25.39 bill. EUR | 29.36 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 390.77 mill. | |
Profitability
| Gross Profit Margin: | 60.46% |
| EBIT Margin: | 14.88% |
| Net Profit Margin: | 14.29% |
| Return on Equity: | 27.40% |
| Return on Assets: | 8.89% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.21% |
| Liquidity II / Quick Ratio: | 0.55% |
| Liquidity III / Current Ratio: | 1.47% |
| Debt / Equity Ratio: | 1.16% |
| Dynam. Debt / Equity Ratio: | 442.84% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2024-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
